乳腺癌与大脑转移:分子见解和临床管理
Mariia Ivanova1, Francesca Maria Porta1,2, Federica Giugliano3,4
1Division of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Genes
|June 28, 2023
概括
乳腺癌脑转移是导致死亡的主要原因. 本综述探讨了它们的生物机制和治疗策略,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 转移研究 转移研究
背景情况:
- 乳腺癌是全球最常见的恶性瘤,也是女性癌症死亡的主要原因.
- 大脑转移显著导致死亡率,通常是由于晚期检测和血脑屏障透的挑战.
- 尽管初级乳腺癌治疗取得了进展,但脑转移患者的治疗结果仍然很差.
研究的目的:
- 阐明乳腺癌脑转移背后的生物学机制.
- 审查当前和新的治疗策略来管理大脑转移.
- 为管理这种复杂的疾病提供前性概述.
主要方法:
- 评估涉及转移的多阶段遗传途径.
- 审查现有和新兴的治疗方式.
- 分析乳腺癌亚型的异质性及其对转移的影响.
主要成果:
- 确定了乳腺癌脑转移形成和进展的多种分子途径.
- 突出了临床管理方面的挑战,包括血脑屏障的透.
- 强调了与大脑转移相关的不良预后,尽管在初级癌症治疗方面取得了进展.
结论:
- 了解乳腺癌大脑转移的生物机制对于改善患者生存至关重要.
- 需要采用综合方法,整合遗传洞察力和先进疗法.
- 进一步研究针对性治疗和克服生物障碍对于更好的管理至关重要.
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K


